Standard on 4,4'-Methylenedianiline (MDA) for General Industry (29 CFR 1910.1050)

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Final-SS-MDA-1218-0184.docx	Supporting Statement A	Uploaded 2016-05-11	Available
29 cfr 1910.1200 eCFR — Code of Federal Regulations.pdf	Supplementary Document	Uploaded 2016-05-11	Available
29 cfr 1910.134 eCFR — Code of Federal Regulations.pdf	Supplementary Document	Uploaded 2016-05-11	Available
eCFR-1910-1050(GEN.-INDUSTRY).docx	Supplementary Document	Uploaded 2016-04-27	Available
60-DayFRNotice 1218-0184.pdf	Supplementary Document	Uploaded 2016-04-27	Available
OSH Act Section 8 USC 657.pdf	Supplementary Document	Uploaded 2016-04-27	Available
OSH Act Section 6 USC 655.pdf	Supplementary Document	Uploaded 2016-04-27	Repair queued
OSH Act Section 2 USC 651.pdf	Supplementary Document	Uploaded 2016-04-27	Repair queued

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
14132	4,4'-Methylenedianiline (MDA) for General Industry (29 CFR 1910.1050)		Modified

ICR Details

OMB Control No: 1218-0184	ICR Reference No: 201604-1218-004
Status: Historical Active	Previous ICR Reference No: 201303-1218-001
Agency/Subagency: DOL/OSHA	Agency Tracking No: 1218-0184(2016)
Title: Standard on 4,4'-Methylenedianiline (MDA) for General Industry (29 CFR 1910.1050)
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 07/19/2016
	Date Received in OIRA: 06/03/2016
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	07/31/2019	36 Months From Approved	07/31/2016
Responses	574	0	659
Time Burden (Hours)	334	0	370
Cost Burden (Dollars)	24,180	0	27,982

---

Abstract: The purpose of this Standard and its information collection requirements is to provide protection for workers from adverse health effects associated with occupational exposure to Methylenedianiline (MDA) in General Industry. Employers must monitor worker exposures within the permissible exposure limits, provide workers with medical examinations and training, and establish and maintain worker exposure-monitoring and medical records.

---

Authorizing Statute(s): US Code: 29 USC 657 Name of Law: The Occupational Safety and Health Act
   US Code: 29 USC 655 Name of Law: The Occupational Safety and Health Act
   US Code: 29 USC 651 Name of Law: The Occupational Safety and Health Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 12966	03/11/2016
30-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 35804	06/03/2016
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
4,4'-Methylenedianiline (MDA) for General Industry (29 CFR 1910.1050)

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	574	659	0	0	-85	0
Annual Time Burden (Hours)	334	370	0	0	-36	0
Annual Cost Burden (Dollars)	24,180	27,982	0	0	-3,802	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The Agency is requesting an adjustment decrease in burden hours from 370 hours to 334 hours. The decrease is the result of a slight decrease in the number of impacted secondary-use plants and a reduction in workers receiving initial medical examinations, receiving exposure monitoring training, and requesting access to records. There is an overall adjustment decrease in capital costs of $3,802 (from $27,982 to $24,180) resulting from a decrease in the cost to analyze a sample of airborne MDA from $119 to $87 each. However, the cost of a medical exam increased from $187 to $207.

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 06/03/2016

---